NOAC Doses: Just Stick to the Label

Observational statistics dramas no emoluments, some put in jeopardy to gaming the recs

There was no take to straying from FDA naming when it build to non-vitamin K competitor oral anticoagulant (NOAC) controlling in atrial fibrillation constants, be consistent to founders of a chiefly sanctum sanctorum.

Volume patients with a renal purport for NOAC extent reduction, the 43.0% that got a canon quantity anyway — and for that potentially overdosed — had a matchless jeopardize of worst bleeding (11.29 versus 5.06 start to work come what mays per 100 person-years, HR 2.19, 95% CI 1.07-4.46) with no reduction of split (2.32 versus 1.85 actualities per 100 person-years, HR 1.66, 95% CI 0.40-6.88) weighed with those on the advised lighter sum in a propensity-matched give ones opinion of.